Status:
WITHDRAWN
Evaluation of Treatment and Prophylaxis of Invasive Fungal Infections in Immuncompromised Patients in Austria (Study P05532)(WITHDRAWN)
Lead Sponsor:
Merck Sharp & Dohme LLC
Conditions:
Mycoses
Eligibility:
All Genders
Brief Summary
The purpose of this program is to determine the frequency of the use of Posaconazole in immunocompromised patients refractory to first line therapy receiving therapeutic treatment based on different p...
Eligibility Criteria
Inclusion
- Immunocompromised patients with refractory IFI
- Patients eligible for prophylactic treatment due to anticipated neutropenia for more than 7 days.
Exclusion
- None
Key Trial Info
Start Date :
July 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2011
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00704951
Start Date
July 1 2008
End Date
June 1 2011
Last Update
August 25 2015
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.